ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

PLoS ONE - United States
doi 10.1371/journal.pone.0009013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

PI3K/Akt-sensitive MEK-independent Compensatory Circuit of ERK Activation in ER-positive PI3K-mutant T47D Breast Cancer Cells

Cellular Signalling
Cell Biology
2010English

ERK/MAPK Regulates ERRγ Expression, Transcriptional Activity and Receptor-Mediated Tamoxifen Resistance in ER+ Breast Cancer

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2014English

Involvement of the Akt Signaling Pathway in ER‑α36/GRP94‑mediated Signaling in Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2014English

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells

PLoS ONE
Multidisciplinary
2014English

Zeylenone, a Naturally Occurring Cyclohexene Oxide, Inhibits Proliferation and Induces Apoptosis in Cervical Carcinoma Cells via PI3K/AKT/mTOR and MAPK/ERK Pathways

Scientific Reports
Multidisciplinary
2017English

CXCL16/CXCR6 Interaction Promotes Endometrial Decidualization via the PI3K/ AKT Pathway

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2019English

Estrogen Receptor (ER ) Level but Not Its ER Cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

NGF Increases FGF2 Expression and Promotes Endothelial Cell Migration and Tube Formation Through PI3K/Akt and ERK/MAPK Pathways in Human Chondrocytes

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Hierarchical Clustering of Activated Proteins in the PI3K and MAPK Pathways in ER-positive, HER2-negative Breast Cancer With Potential Therapeutic Consequences

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy